Popular weight-loss drugs Ozempic and Wegovy may slow biological aging

Popular weight-loss drugs Ozempic and Wegovy may slow biological aging. Researchers found that semaglutide, the active ingredient in Ozempic and Wegovy, slowed biological aging markers in adults with HIV, marking the first clinical evidence that the drug may influence human aging.

A apuração publicada por www.sciencedaily.com vira base para uma leitura editorial direta e contextualizada.

Trechos de apoio da pauta: Researchers found that semaglutide, the active ingredient in Ozempic and Wegovy, slowed biological aging markers in adults with HIV, marking the first clinical evidence that the drug may influence human aging. Although the findings are encouraging, scientists say larger studies are needed before concluding that the medication can help people age more slowly.

• Ponto de atenção: popular.
• Ponto de atenção: weight.
• Ponto de atenção: loss.

Em resumo, a leitura editorial acompanha o impacto do tema no nicho Agro. Quando fizer sentido, a referência complementar pode ser acessada em agronegócio.